Get more replies from employers
Send a job-specific resume in minutes.
Leidos Biomedical Research, Inc. is seeking a CLIA Director for the Molecular Characterization Laboratory at the Frederick National Laboratory in Frederick, MD. The role directs two CLIA laboratories, reviews NGS results, and oversees assay development and validation.
You'll join the senior leadership team, contribute to translational studies, and mentor staff while ensuring CLIA compliance and quality standards in a high-stakes oncology research environment.
Job ID: req4663
Employee Type: nonexempt full-time
Division: Clinical Research Directorate
Facility: Frederick: Ft Detrick
Location: PO Box B, Frederick, MD 21702 USA
The Frederick National Laboratory is operated by Leidos Biomedical Research, Inc. The lab addresses some of the most urgent and intractable problems in the biomedical sciences in cancer and AIDS, drug development and first-in-human clinical trials, applications of nanotechnology in medicine, and rapid response to emerging threats of infectious diseases.
The Molecular Characterization Laboratory (MoCha) is part of Leidos Biomedical Research’s Clinical Research Directorate (CRD) at the Frederick National Laboratory for Cancer Research. Our laboratory consists of a dynamic team of over 40 scientific, informatics and support staff. For 14 years, MoCha has worked closely with the National Cancer Institute’s Division of Cancer Treatment and Diagnosis (DCTD) in support of DCTD-sponsored clinical trials and pre-clinical studies. We are dedicated to implementing cutting-edge genomic technologies to identify new predictive biomarkers and to make translational discoveries that will improve the lives of patients with cancer.
The successful candidate will serve as CLIA Director of the Molecular Characterization Laboratory’s two CLIA laboratories, directly participating in review of next-generation sequencing (NGS) and other clinical assay results and generation of the final patient reports. This role will provide critical support for NCI-sponsored clinical studies to include clinical trial management, regulation and protocol development for the large NCI precision oncology initiatives ComboMATCH, iMATCH and myeloMATCH. The position will oversee the development and/or validation of new clinical assays and genomic technologies. The successful candidate will be part of the senior leadership team and expected to make substantial contributions to the overall success of the laboratory including presenting findings at scientific conferences and publish in peer-reviewed journals.
This position will be full-time onsite and located in Frederick, Maryland.
All qualified applicants will receive consideration for employment without regard to sex, race, ethnicity, color, age, national origin, citizenship, religion, physical or mental disability, medical condition, genetic information, pregnancy, family structure, marital status, ancestry, domestic partner status, sexual orientation, gender identity or expression, veteran or military status, or any other basis prohibited by law. Leidos will also consider for employment qualified applicants with criminal histories consistent with relevant laws.
Pay and benefits are fundamental to any career decision. That's why we craft compensation packages that reflect the importance of the work we do for our customers. Employment benefits include competitive compensation, Health and Wellness programs, Income Protection, Paid Leave and Retirement. More details are available here
181,200.00 - 303,250.00 USD
The posted pay range for this job is a general guideline and not a guarantee of compensation or salary. Additional factors considered in extending an offer include, but are not limited to, responsibilities of the job, education, experience, knowledge, skills, and abilities as well as internal equity, and alignment with market data.
The salary range posted is a full-time equivalent salary and will vary depending on scheduled hours for part time positions